|
Clinical Studies
Citations 51-60 of 354 total displayed.
|
Past content
(since Nov 2000):
|
- Articles
Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans
- Naomi D.L. Fisher, A. H. Jan Danser, J. Nussberger, William P. Dole, and Norman K. Hollenberg
Circulation published June 16, 2008, doi:10.1161/CIRCULATIONAHA.108.767202
[Abstract]
- Articles
Effect of Doxazosin Gastrointestinal Therapeutic System as Third-Line Antihypertensive Therapy on Blood Pressure and Lipids in the Anglo-Scandinavian Cardiac Outcomes Trial
- Neil Chapman, Choon Lan Chang, Björn Dahlöf, Peter S. Sever, Hans Wedel, Neil R. Poulter on behalf of the ASCOT Investigators
Circulation published June 16, 2008, doi:10.1161/CIRCULATIONAHA.107.737957
[Abstract]
- Editorials
Damage Control for Renal Artery Stenting
- John A. Bittl
Circulation 2008;117:2724-2726, doi:10.1161/CIRCULATIONAHA.108.776732
[Full text]
- Controversies in Cardiovascular Medicine
Thiazide-Type Diuretics and β-Adrenergic Blockers as First-Line Drug Treatments for Hypertension
- Jeffrey A. Cutler and Barry R. Davis
Circulation 2008;117:2691-2705, doi:10.1161/CIRCULATIONAHA.107.709931
[Full text]
- Controversies in Cardiovascular Medicine
Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension
- Franz H. Messerli, Sripal Bangalore, and Stevo Julius
Circulation 2008;117:2706-2715, doi:10.1161/CIRCULATIONAHA.107.695007
[Full text]
- Correspondence
Letter Regarding Article by Hood et al, "The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio"
- Paolo Mulatero, Alberto Milan, and Franco Veglio
Circulation 2008;117:e151, doi:10.1161/CIRCULATIONAHA.107.738757
[Full text]
- Correspondence
Response to Letter Regarding Article, "The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio"
- Morris J. Brown, Susan J. Hood, Michael J. Ashby, and Kevin P. Taylor
Circulation 2008;117:e152, doi:10.1161/CIRCULATIONAHA.107.744250
[Full text]
- Health Services and Outcomes Research
Effect of Board Certification on Antihypertensive Treatment Intensification in Patients With Diabetes Mellitus
- Alexander Turchin, Maria Shubina, Anna H. Chodos, Jonathan S. Einbinder, and Merri L. Pendergrass
Circulation 2008;117:623-628; published online before print as doi:10.1161/CIRCULATIONAHA.107.733949
[Abstract]
[Full text]
- Articles
Effect of Board Certification on Antihypertensive Treatment Intensification in Patients With Diabetes Mellitus
- Alexander Turchin, Maria Shubina, Anna H. Chodos, Jonathan S. Einbinder, and Merri L. Pendergrass
Circulation published January 22, 2008, doi:10.1161/CIRCULATIONAHA.107.733949
[Abstract]
- Congenital Heart Disease
Implantable Cardioverter-Defibrillators in Tetralogy of Fallot
- Paul Khairy, Louise Harris, Michael J. Landzberg, Sangeetha Viswanathan, Amanda Barlow, Michael A. Gatzoulis, Susan M. Fernandes, Luc Beauchesne, Judith Therrien, Philippe Chetaille, Elaine Gordon, Isabelle Vonder Muhll, and Frank Cecchin
Circulation 2008;117:363-370; published online before print as doi:10.1161/CIRCULATIONAHA.107.726372
[Abstract]
[Full text]
|
|
